Clinical Trial Update: A Trial to Evaluate Efficacy and Safety of the Combination Therapy of Genexol®-PM Plus Carboplatin® Compared to Genexol® Plus Carboplatin® as a Firstline Treatment in Subjects With Ovarian Cancer [Phase 2]

View source ↗

Summary

A Phase 2 randomized trial evaluating efficacy and safety of Genexol-PM plus carboplatin versus Genexol plus carboplatin as first-line treatment in ovarian canc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Genexol-PM (paclitaxel)

Snippet

Sponsor: Samyang Biopharmaceuticals Corporation | Conditions: Ovarian Cancer | Phase 2 | Status: COMPLETED